SCHEMBL3832902

SCHEMBL3832902

Nc1ncnc2c1c(I)nn2Cc1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
PKM P14618 1/20 0.47
PIK3CG P48736 6/20 0.46
PIK3CD O00329 6/20 0.46
PIK3CA P42336 3/20 0.46
PIK3CB P42338 3/20 0.46
PRKDC P78527 2/20 0.46
SRC P12931 2/20 0.43
KDR P35968 2/20 0.43
PI4KB Q9UBF8 2/20 0.43
ABL1 P00519 1/20 0.43
EGFR P00533 1/20 0.43
HCK P08631 1/20 0.43
MTOR P42345 1/20 0.43
EPHB4 P54760 1/20 0.43
CSF1R P07333 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RET P07949 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2965087 0.86 PIK3CD (0.42) PIK3CGPIK3CDPIK3CAPIK3CBPRKDC
SCHEMBL16701733 0.83 CHRM2 (0.42) PIK3CGPIK3CDPIK3CAPIK3CBPRKDC
SCHEMBL19731411 0.81 BTK (0.60) PIK3CGPIK3CDPIK3CAPIK3CBPRKDC
SCHEMBL29589300 0.81 BTK (0.60) PIK3CGPIK3CDPIK3CAPIK3CBPRKDC
SCHEMBL25678064 0.78 PIK3CG (0.48) PIK3CGPIK3CDPIK3CAPIK3CBPRKDC
SCHEMBL16236697 0.78 DYRK3 (0.48) ALDH1A1PKMPIK3CGPIK3CDPIK3CA
SCHEMBL27882598 0.77 PIK3CG (0.65) PIK3CGPIK3CDPIK3CAPIK3CBPRKDC
SCHEMBL17582622 0.76 PIK3CD (0.50) PIK3CGPIK3CDPIK3CAPIK3CBPRKDC
SCHEMBL25678268 0.76 PIK3CG (0.44) PIK3CGPIK3CDPIK3CAPIK3CBPRKDC
SCHEMBL17331779 0.75 PIK3CG (0.48) PIK3CGPIK3CDPIK3CAPIK3CBPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730148-A4 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LAB (US) 2009-08-19 EP disclosed
EP-1730148-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS Abbott Laboratories (US) 2006-12-13 EP disclosed
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABBOTT LABORATORIES 2006-02-02 US disclosed
WO-2005074603-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LABORATORIES (US) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABL1, MAP3K19, MAP3K20 ALDH1A1 1952/4885PKM 552/4885PIK3CG 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.